Impact of early mobilization on glycemic control and ICU-acquired weakness in critically ill patients who are mechanically ventilated

Chest

Volumn 146, Issue 3, 2014, Pages 583-589

  Patel, Bhakti K ^a   Pohlman, Anne S ^a   Hall, Jesse B ^a   Kress, John P ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DRUG DOSE INCREASE; DRUG UTILIZATION; FEMALE; GLYCEMIC CONTROL; HUMAN; ICU ACQUIRED WEAKNESS; INCIDENCE; INSULIN TREATMENT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; OCCUPATIONAL THERAPY; PHYSIOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SECONDARY ANALYSIS; WEAKNESS; CRITICAL ILLNESS; DOSE RESPONSE; EXERCISE; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; IMMOBILIZATION; INSULIN RESISTANCE; METABOLISM; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; STATISTICAL MODEL; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE; FEMALE; HUMANS; HYPERGLYCEMIA; IMMOBILIZATION; INSULIN; INSULIN RESISTANCE; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; MUSCLE STRENGTH; MUSCLE WEAKNESS; PHYSICAL THERAPY MODALITIES; RESPIRATION, ARTIFICIAL; TREATMENT OUTCOME;

EID: 84907225878     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.13-2046     Document Type: Article

References (44)

1. Levine S, Nguyen T, Taylor N, et al. Rapid disuse atrophy of diaphragm fibers in mechanically ventilated humans. N Engl J Med. 2008; 358 (13): 1327-1335.
2. Herridge MS, Tansey CM, Matté A, et al; Canadian Critical Care Trials Group. Functional disability 5 years after acute respiratory distress syndrome. N Engl J Med. 2011; 364 (14): 1293-1304.
3. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010; 304 (16): 1787-1794.
4. De Jonghe B, Sharshar T, Lefaucheur JP, et al; Groupe de Réfl exion et d'Etude des Neuromyopathies en Réanimation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002; 288 (22): 2859-2867.
5. de Letter MA, Schmitz PI, Visser LH, et al. Risk factors for the development of polyneuropathy and myopathy in criticallyill patients. Crit Care Med. 2001; 29 (12): 2281-2286.
6. Garnacho-Montero J, Amaya-Villar R, García-Garmendía JL, Madrazo-Osuna J, Ortiz-Leyba C. Effect of critical illness polyneuropathy on the withdrawal from mechanical ventilation and the length of stay in septic patients. Crit Care Med. 2005; 33 (2): 349-354.
7. De Jonghe B, Bastuji-Garin S, Sharshar T, Outin H, Brochard L. Does ICU-acquired paresis lengthen weaning from mechanical ventilation? Intensive Care Med. 2004; 30 (6): 1117-1121.
8. Leijten FS, Harinck-de Weerd JE, Poortvliet DC, de Weerd AW. The role of polyneuropathy in motor convalescence after prolonged mechanical ventilation. JAMA. 1995; 274 (15): 1221-1225.
9. Garnacho-Montero J, Madrazo-Osuna J, García-Garmendia JL, et al. Critical illness polyneuropathy: risk factors and clinical consequences. A cohort study in septic patients. Intensive Care Med. 2001; 27 (8): 1288-1296.
10. Stevens RD, Marshall SA, Cornblath DR, et al. A framework for diagnosing and classifying intensive care unit-acquired weakness. Crit Care Med. 2009; 37(suppl 10): S299-S308.
11. Schweickert WD, Pohlman MC, Pohlman AS, et al. Early physical and occupational therapy in mechanically ventilated, criticallyill patients: a randomised controlled trial. Lancet. 2009; 373 (9678): 1874-1882.
12. de Jonghe B, Lacherade JC, Sharshar T, Outin H. Intensive care unit-acquired weakness: risk factors and prevention. Crit Care Med. 2009; 37 (suppl 10): S309-S315.
13. Langouche L, Van den Berghe G. Glucose metabolism and insulin therapy. Crit Care Clin. 2006; 22 (1): 119-129.
14. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in criticallyill patients. N Engl J Med. 2001; 345 (19): 1359-1367.
15. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006; 354 (5): 449-461.
16. Hermans G, Schrooten M, Van Damme P, et al. Benefits of intensive insulin therapy on neuromuscular complications in routine daily critical care practice: a retrospective study. Crit Care. 2009; 13 (1): R5.
17. Van den Berghe G, Wouters PJ, Bouillon R, et al. Outcome benefi t of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003; 31 (2): 359-366.
18. Finfer S, Chittock DR, Su SY, et al; NICESUGAR Study Investigators. Intensive versus conventional glucose control in criticallyill patients. N Engl J Med. 2009; 360 (13): 1283-1297.
19. Brunkhorst FM, Engel C, Bloos F, et al; German Competence Network Sepsis (SepNet). Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008; 358 (2): 125-139.
20. Henriksen EJ. Invited review: effects of acute exercise and exercise training on insulin resistance. J Appl Physiol (1985). 2002; 93 (2): 788-796.
21. Petersen AM, Pedersen BK. The antiinfl ammatory effect of exercise. J Appl Physiol (1985). 2005; 98 (4): 1154-1162.
22. Kress JP, Pohlman AS, O'Connor MF, Hall JB. Daily interruption of sedative infusions in criticallyill patients undergoing mechanical ventilation. N Engl J Med. 2000; 342 (20): 1471-1477.
23. Girard TD, Kress JP, Fuchs BD, et al. Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial. Lancet. 2008; 371 (9607): 126-134.
24. Kleyweg RP, van der Meché FG, Meulstee J. Treatment of Guillain-Barré syndrome with high-dose gammaglobulin. Neurology. 1988; 38 (10): 1639-1641.
25. Kleyweg RP, van der Meché FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barré syndrome. Muscle Nerve. 1991; 14 (11): 1103-1109.
26. Meikle AW, Tyler FH. Potency and duration of action of glucocorticoids. Effects of hydrocortisone, prednisone and dexamethasone on human pituitaryadrenal function. Am J Med. 1977; 63 (2): 200-207.
27. Matthews JN, Altman DG, Campbell MJ, Royston P. Analysis of serial measurements in medical research. BMJ. 1990; 300 (6719): 230-235.
28. Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001; 51 (3): 540-544.
29. Bochicchio GV, Sung J, Joshi M, et al. Persistent hyperglycemia is predictive of outcome in criticallyill trauma patients. J Trauma. 2005; 58 (5): 921-924.
30. Witt NJ, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest. 1991; 99 (1): 176-184.
31. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of criticallyill patients. Mayo Clin Proc. 2003; 78 (12): 1471-1478.
32. Egi M, Bellomo R, Stachowski E, French CJ, Hart G. Variability of blood glucose concentration and short-term mortality in criticallyill patients. Anesthesiology. 2006; 105 (2): 244-252.
33. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000; 355 (9206): 773-778.
34. Vincent AM, McLean LL, Backus C, Feldman EL. Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J. 2005; 19 (6): 638-640.
35. Van Cromphaut SJ, Vanhorebeek I, Van den Berghe G. Glucose metabolism and insulin resistance in sepsis. Curr Pharm Des. 2008; 14 (19): 1887-1899.
36. Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe G. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab. 2004; 89 (1): 219-226.
37. Pohlman MC, Schweickert WD, Pohlman AS, et al. Feasibility of physical and occupational therapy beginning from initiation of mechanical ventilation. Crit Care Med. 2010; 38 (11): 2089-2094.
38. Kennedy JW, Hirshman MF, Gervino EV, et al. Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes. Diabetes. 1999; 48 (5): 1192-1197.
39. Devlin JT, Hirshman M, Horton ED, Horton ES. Enhanced peripheral and splanchnic insulin sensitivity in NIDDM men after single bout of exercise. Diabetes. 1987; 36 (4): 434-439.
40. Hermans G, Wilmer A, Meersseman W, et al. Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit. Am J Respir Crit Care Med. 2007; 175 (5): 480-489.
41. Hough CL, Steinberg KP, Taylor Thompson B, Rubenfeld GD, Hudson LD. Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS. Intensive Care Med. 2009; 35 (1): 63-68.
42. Gore DC, Wolf SE, Sanford AP, Herndon DN, Wolfe RR. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol Metab. 2004; 286 (4): E529-E534.
43. Agus MS, Javid PJ, Ryan DP, Jaksic T. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. J Pediatr Surg. 2004; 39 (6): 839-844.
44. Batt J, dos Santos CC, Cameron JI, Herridge MS. Intensive care unitacquired weakness: clinical phenotypes and molecular mechanisms. Am J Respir Crit Care Med. 2013; 187 (3): 238-246.